bpc-157 dopamine bpc 157 receptors The interaction of pentadecap eptide BPC 157 with adrenergic and BPC-157 Benefits: What the Research

KLOW is not an FDA-approved treatment

There's another one that's getting increasing attention that's worth mentioning, which is thymacin beta-4 and a related peptide, which is T-A-N-E-C-E-R

Potential risks Serious risks and adverse events include: Allergic reaction to the medications or dye used in the injection Shoulder infection Depigmentation of the skin around the injection site (a whitening of the skin) Local fat atrophy around the injection site (thinning of the skin) Rupture of a tendon located in the path of the injection Nerve damage near the shoulder joint Bleeding at the injection site In addition to the above, corticosteroid injections increase the risk of: High blood pressure High blood sugar Decreased immune function Decrease in bone mineral density Bone infection (osteonecrosis) Reproductive hormone imbalance Metabolic changes (eg, increased appetite, weight gain, and fluid retention) These risks are typically associated with higher doses of corticosteroids, multiple injections, and for people with underlying medical conditions such as diabetes and heart problems

Sikiric P, Seiwerth S, Brcic L, Sever M, Klicek R, Radic B, et al

M.KauwellG

Research overview Other vial-size protocols